Deficient angiogenesis in redox-dead Cys17Ser PKARIα knock-in mice

Nature Communications

Volumn 6, Issue , 2015, Pages

  Burgoyne, Joseph R ^a   Rudyk, Olena ^a   Cho, Hyun Ju ^a   Prysyazhna, Oleksandra ^a   Hathaway, Natasha ^a   Weeks, Amanda ^a   Evans, Rachel ^b   Ng, Tony ^b   Schröder, Katrin ^c   Brandes, Ralf P ^c   Shah, Ajay M ^d   Eaton, Philip ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GOETHE UNIVERSITY   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYSTEINE; PKARI ALPHA PROTEIN; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SERINE; UNCLASSIFIED DRUG; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IALPHA; VASCULOTROPIN A;

BLOOD SYSTEM DISORDER; CARDIOVASCULAR DISEASE; CATALYSIS; ENZYME ACTIVITY; GROWTH; LIMB; PROTEIN; REDOX CONDITIONS; REGENERATION; RODENT; TUMOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CONTROLLED STUDY; FEMALE; LIMB ISCHEMIA; MOUSE; NONHUMAN; OXIDATION; PHENOTYPE; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR GROWTH; ANIMAL; AORTA; BOVINE; C57BL MOUSE; ENDOTHELIUM CELL; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; HINDLIMB; IMMUNOPRECIPITATION; ISCHEMIA; MALE; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; VASCULARIZATION;

MUS;

ANIMALS; AORTA; CATTLE; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GENE KNOCK-IN TECHNIQUES; HINDLIMB; IMMUNOPRECIPITATION; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84938915667     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8920     Document Type: Article

References (34)

1. Mitsos, S. et al. Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials. Angiogenesis 15, 1-22 (2012
2. Ferrara, N. and Kerbel, R. S. Angiogenesis as a therapeutic target. Nature 438, 967-974 (2005
3. Woolley, J. F., Corcoran, A., Groeger, G., Landry, W. D. and Cotter, T. G. Redox-regulated growth factor survival signaling. Antioxid. Redox Signal. 19, 1815-1827 (2013
4. DeYulia, Jr. G. J., Carcamo, J.M., Borquez-Ojeda, O., Shelton, C. C. and Golde, D.W. Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilitates cell signaling. Proc. Natl Acad. Sci. USA 102, 5044-5049 (2005
5. Roy, S., Khanna, S. and Sen, C. K. Redox regulation of the VEGF signaling path and tissue vascularization: Hydrogen peroxide, the common link between physical exercise and cutaneous wound healing. Free Radic. Biol. Med. 44, 180-192 (2008
6. Ushio-Fukai, M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc. Res. 71, 226-235 (2006
7. Ushio-Fukai, M. et al. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 91, 1160-1167 (2002
8. Kang, D. H. et al. Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol. Cell 44, 545-558 (2011
9. Schroder, K. et al. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ. Res. 110, 1217-1225 (2012
10. Craige, S. M. et al. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 124, 731-740 (2011
11. Zhang, M. et al. NADPH oxidase-4 mediates protection against chronic loadinduced stress in mouse hearts by enhancing angiogenesis. Proc. Natl Acad. Sci. USA 107, 18121-18126 (2010
12. Brennan, J. P. et al. Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J. Biol. Chem. 281, 21827-21836 (2006
13. Burgoyne, J. R. and Eaton, P. Transnitrosylating nitric oxide species directly activate type I protein kinase A, providing a novel adenylate cyclaseindependent cross-talk to beta-adrenergic-like signaling. J. Biol. Chem. 284, 29260-29268 (2009
14. Lu, Y. et al. Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway. Proc. Natl Acad. Sci. USA 108, 2957-2962 (2011
15. Bir, S. C., Xiong, Y., Kevil, C. G. and Luo, J. Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases. Cardiovasc. Res. 95, 7-18 (2012
16. Sarma, G. N. et al. Structure of D-AKAP2:PKA RI complex: insights into AKAP specificity and selectivity. Structure 18, 155-166 (2010
17. Smith, F. D. et al. AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat. Cell Biol. 12, 1242-1249 (2010
18. Nguyen, A. et al. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol. Cell Biol. 22, 3035-3045 (2002
19. Baker, M. et al. Use of the mouse aortic ring assay to study angiogenesis. Nat. Protoc. 7, 89-104 (2012)
20. Tojo, T. et al. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111, 2347-2355 (2005
21. Koch, S. and Claesson-Welsh, L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb. Perspect. Med. 2, a006502 (2012
22. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23-33 (2002
23. Miller, 3rd E. R. et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Int. Med. 142, 37-46 (2005
24. Vainio, H. Chemoprevention of cancer: lessons to be learned from betacarotene trials. Toxicol. Lett. 112-113, 513-517 (2000
25. Omenn, G. S. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future. Eur. J. Cancer Prev. 16, 184-191 (2007
26. Stubbert, D. et al. Protein kinase G Ialpha oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide. Hypertension 64, 1344-1351 (2014
27. Greiner, R. et al. Polysulfides link H2S to protein thiol oxidation. Antioxid. Redox Signal. 19, 1749-1765 (2013
28. Meng, D. et al. NADPH oxidase 4 mediates insulin-stimulated HIF-1alpha and VEGF expression, and angiogenesis in vitro. PloS ONE 7, e48393 (2012
29. Wu, X. and Williams, K. J. NOX4 pathway as a source of selective insulin resistance and responsiveness. Arterioscler. Thromb. Vasc. Biol. 32, 1236-1245 (2012
30. Zhuang, J. et al. NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction. Free Radic. Biol. Med. 49, 227-236 (2010
31. Rennel, E. et al. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. Br. J. Cancer 98, 1250-1257 (2008
32. Nowak, D. G. et al. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J. Cell Sci. 121, 3487-3495 (2008
33. Burgoyne, J. R. and Eaton, P. Detecting disulfide-bound complexes and the oxidative regulation of cyclic nucleotide-dependent protein kinases by H2O2. Methods Enzymol. 528, 111-128 (2013
34. van Beijnum, J. R., Rousch, M., Castermans, K., van der Linden, E. and Griffioen, A. W. Isolation of endothelial cells from fresh tissues. Nat. Protoc. 3, 1085-1091 (2008